Company profile

We are an early-stage MedTech company developing the world’s first real-time Continuous Multi-Metabolite Monitor (CMM®). This breakthrough technology will provide people living with diabetes with simultaneous, real-time measurements of key metabolites such as glucose, ketones, and lactate. Access to these insights is vital for managing therapies like insulin replacement and SGLT-2 inhibitors, helping to prevent hospitalizations, reduce complications, and lower long-term healthcare costs. Our solution transforms diabetes care by enabling safer, more informed treatment decisions.

Beyond diabetes, CMM® has the potential to improve outcomes in other chronic conditions — including cardiovascular and kidney disease — setting a new benchmark in personalized healthcare.